Inventor
KESICKI EDWARD A
US54 patents
⚠️ This page may combine multiple inventors who share the name “KESICKI EDWARD A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ICOS CORP
23 patentsUS7932260B2Apr 26, 2011
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP221 citations99
US6949535B2Sep 27, 2005
Inhibitors of human phosphatidyl-inositol 3-kinase delta
ICOS CORP172 citations99
US6667300B2Dec 23, 2003
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP174 citations99
US6518277B1Feb 11, 2003
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP272 citations99
US8980901B2Mar 17, 2015
5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP39 citations98
US8586597B2Nov 19, 2013
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP36 citations98
USRE44599ENov 12, 2013
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP44 citations98
US9487772B2Nov 8, 2016
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP19 citations96
US8993583B2Mar 31, 2015
5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP22 citations96
US8779131B2Jul 15, 2014
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP30 citations96
US6423710B1Jul 23, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP47 citations95
US10010550B2Jul 3, 2018
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP11 citations92
US9149477B2Oct 6, 2015
5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP17 citations92
US6716871B2Apr 6, 2004
Cyclic AMP-specific phosphodie sterase inhibitors
ICOS CORP14 citations92
US6458787B1Oct 1, 2002
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP24 citations91
US7067506B2Jun 27, 2006
Compounds useful for inhibiting Chk1
ICOS CORP31 citations90
US10695349B2Jun 30, 2020
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP2 citations84
US10398695B2Sep 3, 2019
Inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP5 citations84
US10336756B2Jul 2, 2019
(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP5 citations84
US7608618B2Oct 27, 2009
Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1
ICOS CORP9 citations81
US10906907B2Feb 2, 2021
Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof
ICOS CORP0 citations73
US6998416B2Feb 14, 2006
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP1 citations62
US7176229B2Feb 13, 2007
Cyclic AMP-specific phosphodiesterase inhibitors
ICOS CORP0 citations51
SADHU CHANCHAL
5 patentsUS8637533B2Jan 28, 2014
Inhibitors of human phosphatidylinositol 3-kinase delta
SADHU CHANCHAL48 citations97
US8623881B2Jan 7, 2014
Inhibitors of human phosphatidylinositol 3-kinase delta
SADHU CHANCHAL41 citations97
US8492389B2Jul 23, 2013
Inhibitors of human phosphatidylinositol 3-kinase delta
SADHU CHANCHAL47 citations97
US8138195B2Mar 20, 2012
Inhibitors of human phosphatidylinositol 3-kinase delta
SADHU CHANCHAL64 citations96
US8653077B2Feb 18, 2014
Inhibitors of human phosphatidylinositol 3-kinase delta
SADHU CHANCHAL39 citations95
HIBERCELL INC
5 patentsUS11667651B2Jun 6, 2023
Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
HIBERCELL INC1 citations59
US12006332B2Jun 11, 2024
Aminopyrimidine derivatives as phosphatidylinositol phosphate kinase inhibitors
HIBERCELL INC0 citations52
US11498929B2Nov 15, 2022
Chromenopyrimidine derivatives as phosphatidylinsitol phosphate kinase inhibitors
HIBERCELL INC0 citations52
US11584763B2Feb 21, 2023
Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
HIBERCELL INC0 citations48
US11919902B2Mar 5, 2024
Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors
HIBERCELL INC0 citations46
PROLINX INC
3 patentsPETRA PHARMA CORP
3 patentsUS11873295B2Jan 16, 2024
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease
PETRA PHARMA CORP3 citations65
US11649227B2May 16, 2023
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease
PETRA PHARMA CORP1 citations53
US12030862B2Jul 9, 2024
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease
PETRA PHARMA CORP0 citations50
FOWLER KERRY W
2 patentsALGOMEDIX INC
2 patentsICOS
1 patentLUITPOLD PHARM INC
1 patentDUNCAN IAIN W
1 patentHALBROOK JAMES W
1 patentDIAZ FRANK
1 patentBIO AFFINITY SYSTEMS
1 patentNeumedics
1 patentShowing the top 50 of 54 patents by PatentIndex Score.